Senvest Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Senvest Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-228,336	Closed	-$900K	–	72
2016 Q2	$900K	Sell	228,336 -261,471	-53%	-$977K	0.07%	60
2016 Q1	$1.52M	Sell	489,807 -604,230	-55%	-$2.02M	0.13%	55
2015 Q4	$5M	Sell	1,094,037 -58,589	-5%	-$278K	0.38%	44
2015 Q3	$5.43M	Hold	1,152,626	–	–	0.39%	49
2015 Q2	$8.25M	Buy	1,152,626 +700	+0.1%	+$5.26K	0.52%	49
2015 Q1	$9.76M	Hold	1,151,926	–	–	0.6%	43
2014 Q4	$10.7M	Buy	1,151,926 +350,481	+44%	+$3.05M	0.76%	41
2014 Q3	$6.68M	Buy	801,445 +207,780	+35%	+$1.92M	0.63%	37
2014 Q2	$6.86M	Buy	593,665 +413,134	+229%	+$4.24M	0.6%	38
2014 Q1	$2.29M	Buy	+180,531	New	+$2.33M	0.18%	65

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Senvest Management's DSCI Position: Q3 2016 in Review

Senvest Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2016, closing a stake of 228,336 shares — an estimated $900K sold.

Senvest Management first reported a position in DSCI in Q1 2014 and held it in 10 quarters. The position peaked at $10.7M in Q4 2014. 61 funds tracked by Wall St. Rank hold DSCI as of Q3 2016.

Senvest Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2016 after selling out during the quarter.
Senvest Management sold 228,336 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2016, an estimated $900K.
Senvest Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 10 quarters.
Senvest Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $10.7M in Q4 2014.
61 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2016.

Based on Senvest Management's 13F filing for Q3 2016, filed 10 Nov 2016.